# Clinical Application of CTDNA in Operable Breast Cancer Patients

> **NCT02797652** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Neoadjuvant chemotherapy before surgery
- **PROCEDURE:** Surgery followed by adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT02797652
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-04
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797652, "Clinical Application of CTDNA in Operable Breast Cancer Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02797652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*